Skip to contentR
Repligen Corp
R
RGENRepligen Corp Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$167.55M$167.55Mderived+0.6% vs Q4 2023 Net Income-$33.87M-$33.87MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$36,501,000N/M Operating Cash Flowderived$39,176,000+34.8% Free Cash Flowderived$33,636,000+87.1% Margins · derivedOperating margin-21.8%−27.7 pt vs Q4 2023
Net margin-20.2%−10.3 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 14, 2025 · 73 d after period end